Get In Touch

Bradycardia is a condition, wherein the heartbeat is too slow i.e., less than 60 beats per minute. The incidence of bradycardia increases with age, as the underlying causes become more frequent. Other factors projected to increase the number of bradycardia cases include rise in obesity, chest pain or palpitations, increase in uptake of irrigated radiofrequency (RF) ablation catheter devices. Electrocardiogram is the primary diagnostic tool for evaluating bradycardia. The global bradycardia market is anticipated to be driven by rapidly growing significance of electrophysiology, a cardiology subspecialty, in the discovery of new treatments and cures for almost all cases of heart condition.

Rise in adoption of Western lifestyle and dietary pattern in emerging markets in Southeast Asia and Latin America is expected to increase prevalence of cardiac disorders. This in turn is likely to propel the global bradycardia market. The market in North America is projected to witness strong growth during the forecast period. However, emerging regions such as Asia Pacific are anticipated to present significant opportunities in the market due to unmet medical needs and improving health care infrastructure.

Bradycardia drugs are used to treat cardiac problems such as abnormal heart rhythm which results in an extremely slow heartbeat. Bradycardia is caused as a result of a heart disease or a disorder which affects the function of the heart. The goal of bradycardia drug therapy is to restore normal cardiac function and prevent life-threatening consequences. Bradycardia causes lightheadedness, fatigue, fainting or near-fainting spells, dizziness, and at times cardiac arrest. The geriatric population is more affected by bradycardia than younger people. Factors such as rise in the number of patients suffering from obesity, increase in chronic diseases, surge in consumption of alcohol & cigarettes, work pressure, and unhealthy lifestyles are expected to drive the global bradycardia market. According to the Centers for Disease Control and Prevention, more than one-third (36.5%) adults in the U.S. suffer from obesity. Increase in research and development activities, rise in the geriatric population, and rich product pipeline are likely to propel the global bradycardia market. However, intense competition and stringent regulatory scenario are projected to restrain the market.

In terms of product, the global bradycardia market can be segmented into drugs and medical devices. The bradycardia market is likely to exhibit steady growth in the next few years due to the growing cardiac health care and medical devices sectors. Strong government support for the health care sector and medical devices industry is expected to augment the global cardiac assist devices market during the forecast period. Based on distribution channel, the global bradycardia market can be divided into hospital pharmacies, retail pharmacies, and online pharmacies.

Geographically, the global bradycardia market can be segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America dominated the global market in 2017 due to the presence of top players, increase in geriatric population, and rise in prevalence of cardiac diseases. According to CDC, an estimated 2.7 million to 6.1 million people in the U.S. experience atrial fibrillation each year. Europe was the second leading market for bradycardia drugs owing to increase in research & development activities and rise in consumption of tobacco. According to the World Health Organization, Europe exhibits high prevalence of tobacco smoking among adults. The market in Asia Pacific is likely to expand at a higher CAGR due to the presence of a large patient pool, rise in prevalence of cardiovascular diseases, surge in disposable income, increase in government initiatives, and high awareness. Emerging regions such as Latin America and Middle East & Africa are projected to present significant opportunities in the bradycardia market during the forecast period.

Key players operating in the global bradycardia market include Abbott Laboratories, Medtronic plc, Berlin Heart GmbH, Abiomed, Inc., Carmat SA, Thoratec Corporation, Teleflex Incorporated, SynCardia Systems, Inc., Teva Pharmaceutical Industries, Mylan N.V., GlaxoSmithKline LLC, Upsher-Smith Laboratories LLC, Sanofi, and Novartis International AG.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.


Bradycardia Market

Pre Book